Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study
Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: GlaxoSmithKline
OpenAlex ID: W1972329806
